{"doc_id": "electrolytes_and_monitoring", "title": "Electrolytes & Monitoring (QT-risk mitigation)", "section": "Potassium (K) target (QT-risk prevention)", "chunk_id": "electrolytes_and_monitoring:0:0", "text": "- Guidelines commonly recommend keeping potassium in the higher end of normal to reduce QT-related arrhythmia risk.\n- Practical target often cited in QT-risk pathways: **K = 4.0–5.0 mEq/L** (individualize to patient context and institutional policy)."}
{"doc_id": "electrolytes_and_monitoring", "title": "Electrolytes & Monitoring (QT-risk mitigation)", "section": "Magnesium (Mg) target (QT-risk prevention)", "chunk_id": "electrolytes_and_monitoring:1:0", "text": "- Correct hypomagnesemia; many QT-risk pathways aim for **Mg >= 2.0 mg/dL** (or high-normal), depending on local practice."}
{"doc_id": "electrolytes_and_monitoring", "title": "Electrolytes & Monitoring (QT-risk mitigation)", "section": "Monitoring / reassessment", "chunk_id": "electrolytes_and_monitoring:2:0", "text": "- Repeat ECG after correcting electrolytes and/or changing QT-prolonging medications.\n- Consider telemetry in higher-risk scenarios (e.g., QTc >= 500 ms, multiple QT-prolonging agents, symptoms, bradycardia, structural heart disease)."}
{"doc_id": "electrolytes_and_monitoring", "title": "Electrolytes & Monitoring (QT-risk mitigation)", "section": "Safety note", "chunk_id": "electrolytes_and_monitoring:3:0", "text": "- These are decision-support targets; final decisions should follow local protocols and the treating clinician’s judgment."}
{"doc_id": "qt_risk_checklist", "title": "QT / TdP Risk Checklist", "section": "High-risk signals", "chunk_id": "qt_risk_checklist:0:0", "text": "- QTc >= 500 ms\n- Rapid QTc increase from baseline\n- Low K and/or low Mg\n- Multiple QT-prolonging agents\n- Bradycardia\n- Structural heart disease (e.g., CHF)\n- Renal dysfunction raising drug exposure"}
{"doc_id": "qt_risk_checklist", "title": "QT / TdP Risk Checklist", "section": "Safer action framing", "chunk_id": "qt_risk_checklist:1:0", "text": "- Correct electrolytes first\n- Review necessity of QT-prolonging agents and consider alternatives\n- Repeat ECG after interventions"}
{"doc_id": "qtguard_kb", "title": "QTGuard Knowledge Base (Starter)", "section": "Required inputs for QT risk triage", "chunk_id": "qtguard_kb:0:0", "text": "- QTc (ms)\n- Potassium (K)\n- Magnesium (Mg)\n- Current medication list (with doses)\n- Renal/hepatic function if available"}
{"doc_id": "qtguard_kb", "title": "QTGuard Knowledge Base (Starter)", "section": "Common QT/TdP risk factors", "chunk_id": "qtguard_kb:1:0", "text": "- QTc >= 500 ms or large delta increase from baseline\n- Hypokalemia / hypomagnesemia\n- Multiple QT-prolonging meds\n- Bradycardia\n- Structural heart disease\n- Recent dose increases / drug interactions that raise concentrations"}
{"doc_id": "qtguard_kb", "title": "QTGuard Knowledge Base (Starter)", "section": "Output rules (demo-safe)", "chunk_id": "qtguard_kb:2:0", "text": "- If QTc/K/Mg missing → safe deferral + request missing inputs\n- If evidence does not support a claim → do not assert it; ask a follow-up question"}
{"doc_id": "safety_guardrails", "title": "Safety Guardrails for QTGuard Outputs", "section": "Grounding rule", "chunk_id": "safety_guardrails:0:0", "text": "- Do not recommend holding or discontinuing a medication unless the evidence supports it.\n- Prefer: \"consider holding\" / \"review necessity\" / \"consider alternative\" when evidence is general."}
{"doc_id": "safety_guardrails", "title": "Safety Guardrails for QTGuard Outputs", "section": "Deferral rule", "chunk_id": "safety_guardrails:1:0", "text": "- If evidence is weak or key context is missing (dose, renal function, full med list), ask a targeted follow-up question."}
